| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Dr. Amy E. HerrIndependent Director | -6.64k | 4.51k | Derivative Exercise and Sale | 47.60 - 48.28 | 2.88k | - |
| 2026-05-05 | Mr. James T. HippelExec. VP of Finance & CFO | -56.96k | 517.15k | Derivative Exercise and Sale | 47.60 - 56.68 | 153.67k | - |
| 2026-05-05 | Mr. James T. HippelExec. VP of Finance & CFO | 5.05k | 240.14k | Derivative Exercise and Retained Stock | 47.60 | 153.67k | 3.39% |
| 2026-05-05 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | -7.06k | 64.06k | Derivative Exercise and Sale | 47.60 - 56.68 | 7.25k | - |
| 2026-05-05 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1.35k | 64.02k | Derivative Exercise and Retained Stock | 47.60 | 7.25k | 22.78% |
| 2026-05-05 | Mr. Kim KeldermanCEO, President & Director | -23.95k | 217.48k | Derivative Exercise and Sale | 47.60 - 56.68 | 65.80k | - |
| 2026-05-05 | Mr. Kim KeldermanCEO, President & Director | 2.74k | 130.47k | Derivative Exercise and Retained Stock | 47.60 | 65.80k | 4.35% |
| 2026-05-01 | Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment | -311.00 | 17.11k | Derivative Exercise and Sale | 55.02 | 6.34k | - |
| 2026-05-01 | Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment | 483.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.34k | 8.25% |
| 2026-04-22 | Mr. Kim KeldermanCEO, President & Director | -1.36k | 79.84k | Derivative Exercise and Sale | 58.58 | 63.06k | - |
| 2026-04-22 | Mr. Kim KeldermanCEO, President & Director | 9.98k | 0.00 | Derivative Exercise and Retained Stock | - | 63.06k | 18.80% |
| 2026-04-22 | Mr. James T. HippelExec. VP of Finance & CFO | -56.10k | 3.29M | Derivative Exercise and Sale | 58.58 | 148.63k | - |
| 2026-04-22 | Mr. James T. HippelExec. VP of Finance & CFO | 5.90k | 0.00 | Derivative Exercise and Retained Stock | - | 148.63k | 4.14% |
| 2026-04-14 | Mr. Kim KeldermanCEO, President & Director | -32.09k | 1.88M | Derivative Exercise and Sale | 58.66 | 53.08k | - |
| 2026-04-14 | Mr. Kim KeldermanCEO, President & Director | 4.41k | 0.00 | Derivative Exercise and Retained Stock | - | 53.08k | 9.07% |
| 2026-04-03 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | -740.00 | 39.32k | Derivative Exercise and Sale | 53.13 | 5.90k | - |
| 2026-04-03 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1.52k | 0.00 | Derivative Exercise and Retained Stock | - | 5.90k | 34.64% |
| 2026-02-17 | Dr. Amy E. HerrIndependent Director | -1.98k | 116.79k | 売り | 59.11 | 2.88k | -40.69% |
| 2026-02-03 | Dr. Amy E. HerrIndependent Director | 22.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.86k | 0.46% |
| 2026-02-03 | Dr. Amy E. HerrIndependent Director | -16.00 | 1.03k | Derivative Exercise and Sale | 64.63 | 4.86k | - |
| 2026-02-01 | Dr. Matthew F. McManusインサイダー | 2.96k | 0.00 | Derivative Exercise and Retained Stock | - | 7.69k | 62.43% |
| 2026-02-01 | Dr. Matthew F. McManusインサイダー | -1.67k | 106.71k | Derivative Exercise and Sale | 64.09 | 7.69k | - |
| 2025-11-03 | Mr. James T. HippelExec. VP of Finance & CFO | 12.84k | 0.00 | Derivative Exercise and Retained Stock | - | 142.72k | 9.89% |
| 2025-11-03 | Mr. James T. HippelExec. VP of Finance & CFO | -11.87k | 742.39k | Derivative Exercise and Sale | 62.57 | 142.72k | - |
| 2025-11-03 | Mr. Kim KeldermanCEO, President & Director | -2.30k | 144.10k | Sale to Issuer | 62.57 | 48.67k | -4.52% |
| 2025-11-03 | Mr. William A. GeistPresident of Protein Sciences Segment | 5.39k | 0.00 | Derivative Exercise and Retained Stock | - | 20.50k | 35.67% |
| 2025-11-03 | Mr. William A. GeistPresident of Protein Sciences Segment | -4.52k | 282.82k | Derivative Exercise and Sale | 62.57 | 20.50k | - |
| 2025-08-25 | Dr. Roeland Nusseインサイダー | -17.04k | 588.23k | Derivative Exercise and Sale | 21.84 - 56.36 | 44.56k | - |
| 2025-08-25 | Mr. Robert V. BaumgartnerIndependent Chairman of the Board | -17.04k | 585.66k | Derivative Exercise and Sale | 21.84 - 56.21 | 44.86k | - |
| 2025-08-15 | Mr. James T. HippelExec. VP of Finance & CFO | 2.08k | 0.00 | Derivative Exercise and Retained Stock | - | 129.88k | 1.63% |
| 2025-08-15 | Mr. James T. HippelExec. VP of Finance & CFO | -1.93k | 103.23k | Derivative Exercise and Sale | 53.60 | 129.88k | - |
| 2025-08-15 | Mr. Kim KeldermanCEO, President & Director | 4.24k | 0.00 | Derivative Exercise and Retained Stock | - | 50.97k | 9.07% |
| 2025-08-15 | Mr. Kim KeldermanCEO, President & Director | -4.31k | 230.75k | Derivative Exercise and Sale | 53.60 | 50.97k | - |
| 2025-08-15 | Dr. Amy E. HerrIndependent Director | 178.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.19k | 5.90% |
| 2025-08-15 | Dr. Amy E. HerrIndependent Director | -101.00 | 5.41k | Derivative Exercise and Sale | 53.60 | 3.19k | - |
| 2025-08-15 | Mr. William A. GeistPresident of Protein Sciences Segment | 1.82k | 0.00 | Derivative Exercise and Retained Stock | - | 15.11k | 13.69% |
| 2025-08-15 | Mr. William A. GeistPresident of Protein Sciences Segment | -803.00 | 43.04k | Derivative Exercise and Sale | 53.60 | 15.11k | - |
| 2025-08-15 | Dr. Matthew F. McManusインサイダー | 1.76k | 0.00 | Derivative Exercise and Retained Stock | - | 4.74k | 59.00% |
| 2025-08-15 | Dr. Matthew F. McManusインサイダー | -880.00 | 47.17k | Derivative Exercise and Sale | 53.60 | 4.74k | - |
| 2025-08-15 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1.19k | 0.00 | Derivative Exercise and Retained Stock | - | 4.39k | 37.29% |
| 2025-08-15 | Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | -527.00 | 28.25k | Derivative Exercise and Sale | 53.60 | 4.39k | - |
| 2025-08-07 | Mr. John L. HigginsIndependent Director | 5.04k | 110.07k | Derivative Exercise and Retained Stock | 21.84 | 65.24k | 8.37% |
| 2025-07-29 | Mr. James T. HippelExec. VP of Finance & CFO | 21.19k | 939.31k | Derivative Exercise and Retained Stock | 44.33 | 127.80k | 19.88% |
| 2025-07-29 | Mr. James T. HippelExec. VP of Finance & CFO | -147.43k | 2.10M | Derivative Exercise and Sale | 44.33 - 58.55 | 127.80k | - |
| 2025-07-22 | Mr. Kim KeldermanCEO, President & Director | 4.53k | 200.68k | Derivative Exercise and Retained Stock | 44.33 | 46.73k | 10.73% |
| 2025-07-22 | Mr. Kim KeldermanCEO, President & Director | -43.65k | 383.67k | Derivative Exercise and Sale | 44.33 - 53.12 | 46.73k | - |
| 2025-07-15 | Mr. Kim KeldermanCEO, President & Director | 3.20k | 141.81k | Derivative Exercise and Retained Stock | 44.33 | 42.20k | 8.20% |
| 2025-07-15 | Mr. Kim KeldermanCEO, President & Director | -32.93k | 233.49k | Derivative Exercise and Sale | 44.33 - 51.42 | 42.20k | - |
| 2025-06-09 | Dr. Amy E. HerrIndependent Director | -1.28k | 6.96k | Derivative Exercise and Sale | 44.33 - 49.77 | 3.02k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。